Nov10

Update 10 November 2026

Update 10 November 2026

Winter is coming. The days and nights are getting colder and, especially with the end of summertime, it is getting dark very early. Happy that I am not still living in Norway, where, even in Oslo, there is almost no daylight for the next few months. Happily, there is still news to report about the Dutch healthcare sector. In this update we cover:

  • Investments in Dutch medtech to total €250 million. Where is the money coming from?
  • Leading Dutch hospital repurchases laboratories from Eurofins to avoid bankruptcy. What is the story?
  • Physiotherapists to get collective labor agreement. Why did this take 23 years?
  • New financing structure for elderly care taking shape. What do we know?

Investments in Dutch medtech to total €250 million

The key goal of a government initiative (Medtech 2035) is to give the Netherlands the “strongest med-tech sector in Europe”. The government has set aside €102.5 million for the initiative, and this will be supplemented by €150 million in financing from Invest-NL (an investment fund owned by the Dutch Ministry of Finance) and €50 million from Philips. MedTech 2035 has  three focus themes:

  • Digitally integrated patient focused care pathways
  • Minimally invasive, image-guided interventions and therapies
  • Advanced diagnostics, patient monitoring, and sensor technologies

The €250 million is a drop in the ocean compared to the total of €5.5 billion required in total investments, but it is believed that the program can lead to 75 new start-ups, 11,000 new jobs and €5 billion in export value.

Hospital repurchases laboratories from Eurofins

Eurofins is one of the largest European providers of analytical laboratory testing. They are active in the Dutch market with approximately twenty subsidiaries. A key area in clinical diagnostics, and in 2023 they acquired the laboratory activities of the Gelre Hospital. Gelre had been struggling financially for a few years, and it sounded like an excellent deal. Eurofins paid €15 million for the laboratory activities, and offered to provide exactly the same services as before to the hospital but for €2.5 million less than the previous costs.

At the beginning everything seemed to go well. The same staff provided services, and quality was fine. Unfortunately, all was not well financially. The Eurofins subsidiary that acquired the laboratory activities (Eurofins Gelre) reported a €5.1 million loss on revenues of €17.4 million in 2023, and in 2024 made a loss of €23.5 million on revenues of €25 million. Main reasons for the large losses were increased staffing costs from €7 to €11 million (but with the same number of staff) and goodwill depreciations of €13.8 million. The overall quality of the administration was so bad that the external accountant refused to sign the annual report.

In October 2025, the management of Gelre was told that the financial situation for the company (renamed Clinical Diagnostics Gelre) was untenable and Eurofins was planning to file for voluntary bankruptcy for the subsidiary. As many of the daily activities of the hospital were dependent on input from the laboratory going through a bankruptcy process was impossible for the hospital and after long negotiations the laboratory activities were repurchased. The price was lower than what Eurofins had paid, but hospital management highlights that the acquired company is in worse shape than when it was sold (understaffed, overdue maintenance, etc.). The hospital expects that the activities will be loss making (due to relatively small scale of operations), but do not have any feasible alternatives.

Physiotherapists to get collective labor agreement

In previous updates we have written about the challenges and opportunities in the physiotherapy sector. Physiotherapists have for the last 23 years not had a collective labor agreement. This is quite strange, because in the Netherlands, and especially in the healthcare sector all employees typically have such agreements. The new agreement has been reached between the main unions and the physiotherapy employers association. The agreement provides a floor for individual agreements between physiotherapists and employers. Employees keep any benefits that are better than what has been agreed and other elements need to be upgraded to be in line with the collective agreement. Physiotherapists will get 2.5% more salary in January 2027and an additional 1% in September.

As reported earlier, physiotherapists seem, in general, to be doing OK financially, so hopefully this will not have an adverse effect on the overall attractiveness of the sector. In addition, it should make working in the sector more attractive, thus reducing the number of physiotherapists leaving the sector.

New financing structure for elderly care taking shape

In earlier updates we have written about the government’s plan to develop a new financing structure for complex elderly care. The timing is uncertain, and changes are not likely to be implemented before 2029. Recently an initial change has been made public. VPT-financed care includes the responsibility of providing food and drink to the clients. Many providers using VPT to finance home care have already stopped doing this and pay their patients to compensate for the reduced service offering.

Zorginsituut Nederland (National Healthcare Institute) responsible for the content of healthcare service offerings, had recently suggested removing food and drink from the VPT-package. This will make the service offering more similar to MPT and PGB, and will potentially reduce costs. Most reactions are positive, except for patient groups who see a risk of under nourishment and under hydration and more work for family and friends. Implementation will be a long-term process as it will require a change to relevant laws, change to VPT-tariffs and a reduction in the personal contribution paid by the client. Most likely this will not be conducted as a separate process but be included in the overall process related to the development of the new financing structure.